Lenvatinib 4mg Capsules$50.00
1–9 boxes
$50.00 each
10–24 boxes
8% off
25+ boxes
10% off
Lenvatinib 4mg Capsules
SKU GME1095Oncology Care
Product Introduction
Lenvatinib 4mg is a targeted cancer medicine for radioiodine-refractory differentiated thyroid cancer and unresectable liver cancer. It is also used with other anticancer medicines for advanced kidney cancer or endometrial cancer in the appropriate treatment setting.
How to use
Take the capsules once daily at the same time, with or without food, and swallow them whole. The daily amount differs between cancer regimens and, in liver cancer, can depend on body weight. Do not open a capsule to divide its contents into a smaller dose.
How it works
Lenvatinib inhibits several signalling proteins, including VEGF and FGF receptors. Blocking these pathways reduces the formation of blood vessels supplying a tumour and interferes with signals that support cancer-cell growth.
Side effects
High blood pressure, diarrhoea, reduced appetite, weight loss, fatigue and hand-foot skin reactions can occur. Serious effects include bleeding, kidney injury, heart problems and bowel perforation. Sudden severe abdominal pain or coughing blood needs emergency care.
Important information
Blood pressure, urine protein, kidney and liver function, thyroid function and electrolytes are monitored during treatment. Planned operations or dental surgery need an interruption plan because wound healing can be impaired. Pregnancy must be avoided during treatment.
Uses
- Radioiodine-refractory differentiated thyroid cancer
- unresectable hepatocellular carcinoma
- selected advanced renal-cell or endometrial cancers within the appropriate combination regimen.
Benefits
Can shrink responsive tumours or slow their progression by targeting cancer-growth and blood-vessel signalling.
What should I do if I miss a lenvatinib dose?
Take the missed dose when remembered if more than 12 hours remain before the next dose. If the next dose is due within 12 hours, skip the missed dose and resume the usual time. Do not double up.
Why are urine protein tests needed?
VEGF-pathway inhibition can affect kidney filtration and allow protein into the urine. A rising protein level may require a treatment pause or dose adjustment before symptoms develop.
Can the medicine affect an operation wound?
Yes. Its effect on blood-vessel formation can delay healing. The surgical and cancer teams arrange when treatment stops and restarts around an operation.
How is benefit measured if I cannot feel the tumour changing?
Scans and cancer-specific measurements assess response. Appetite, pain or energy may improve, remain unchanged or worsen for reasons that do not directly reflect tumour size.
Kinase inhibitor: medicine blocking cellular signalling enzymes. VEGF: signal promoting blood-vessel growth. Radioiodine-refractory: no longer responding adequately to radioactive iodine. Proteinuria: protein in urine. Hand-foot reaction: painful redness or thickening of palms and soles.; AR: Lenvatinib 4mg كبسولات; FR: Lenvatinib 4mg gélules; PT: Lenvatinib 4mg cápsulas; ES: Lenvatinib 4mg cápsulas; RU: Lenvatinib 4mg капсулы; ID: Lenvatinib 4mg kapsul; VI: Lenvatinib 4mg viên nang; MS: Lenvatinib 4mg kapsul; TL: Lenvatinib 4mg kapsula; ZH-SG: Lenvatinib 4mg 胶囊